Monument Capital Management Gilead Sciences, Inc. Transaction History
Monument Capital Management
- $357 Million
- Q4 2024
A detailed history of Monument Capital Management transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Monument Capital Management holds 7,154 shares of GILD stock, worth $686,998. This represents 0.19% of its overall portfolio holdings.
Number of Shares
7,154
Previous 6,133
16.65%
Holding current value
$686,998
Previous $514,000
28.4%
% of portfolio
0.19%
Previous 0.14%
Shares
12 transactions
Others Institutions Holding GILD
# of Institutions
1,990Shares Held
992MCall Options Held
10.5MPut Options Held
9.85M-
Black Rock Inc. New York, NY121MShares$11.6 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA115MShares$11.1 Billion0.18% of portfolio
-
Capital World Investors Los Angeles, CA76.5MShares$7.35 Billion1.03% of portfolio
-
Capital Research Global Investors Los Angeles, CA61.8MShares$5.93 Billion1.12% of portfolio
-
State Street Corp Boston, MA60.2MShares$5.78 Billion0.21% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $120B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...